You can access the report at the following link: … BW_081918_Gumshoe
About Bob Weir
3242 Articles
Bob Weir has over 50 years of investment research and analytical experience in both the equity and fixed-income sectors, and in the commercial real estate industry. He joined eResearch in 2004 and was its President, CEO, and Managing Director, Research Services until December 2018. Prior to joining eResearch, Bob was at Dominion Bond Rating Service (DBRS).
Related Articles
![](https://eresearch.com/wp-content/uploads/2019/06/StockGumshoe-crop-7.jpg)
Market Pundits
Doc Gumshoe: Medical Issues – March 7, 2019
eResearch is pleased to provide the latest Stock Gumshoe widely-promoted mystery company. [more]
![Healthtech Update](https://eresearch.com/wp-content/uploads/2020/09/2020-09-02-Healthtech-Update-FI.jpg)
Analyst Articles
HealthTech Quarterly Update – Acquisitions Continue as Companies Focus on Remote Care and U.S. Expansion
This past quarter, the HealthTech industry experienced a significant boost in activity and growth as the pandemic stimulated the digitization of various healthcare services. However, companies working directly with patients for physical appointments experienced various complications due to procedures being postponed. [more]
![](https://eresearch.com/wp-content/uploads/2021/03/2021-02-17-Well-Health-CRH-Medical-FI.png)
Analyst Articles
WELL Health to Triple Revenue with $369.2M CRH Medical Acquisition
WELL Health’s buying spree continues with a major acquisition with C$302.5M financing led by Mr. Li Ka-shing. The acquisition will add annual revenue of US$100M with a run-rate of US$120 million to Well Health’s books. CRH currently has an EBITDA operating margin of 40%. [more]